Skip to main content
Premium Trial:

Request an Annual Quote

For Smarts?

Though editing human embryos to boost intelligence isn't yet possible, three researchers write in an opinion piece at Stat News that there is already a way to gauge which embryo may be the smartest and a company to help prospective parents do that. But they argue there should be limits to such testing.

Researchers have already developed genetic prediction scores for intelligence, which could be applied to genetic profiles of embryos, write the Hastings Center's Erik Parens and Paul Appelbaum and Wendy Chung, both from Columbia University. They add the company Genomic Prediction is now offering predictive tests to parents-to-be to gauge their embryos' risk of developing diseases like diabetes, hypertension, or breast cancer, but also of having a very low IQ. The company tells them they do not test for high IQ, as it is unethical.

Parens, Appelbaum, and Chung agree it is unethical and argue that it would worsen the gaps between those who can afford testing and those who cannot. They call for regulation of the space to impose limits on what kind of testing can be done with embryos. "Stifling progress in eliminating genetic diseases is not our goal," they write. "But creating regulations to prevent embryo profiling from being abused might be one end that could inspire our elected representatives to reach across the aisle."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.